Trial NCT05374603

View at ClinicalTrials.gov 
Org. Study IDs: D5083C00002

Last trial update was posted on 2024-03-01

MeSH Interventions

Durvalumab

MeSH Conditions


Other Conditions

Lung Cancer

Stopping Reasons

The sponsor needs to comprehensively evaluate the benefit and risk of the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID